tradingkey.logo
tradingkey.logo
Suchen

Merck & Co Inc

MRK
Zur Watchlist hinzufügen
126.790USD
-2.770-2.14%
Handelsschluss 07/06, 16:00ETKurse um 15 Minuten verzögert
313.12BMarktkapitalisierung
35.54KGV TTM

mehr Informationen über Merck & Co Inc Unternehmen

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Merck & Co Inc Informationen

BörsenkürzelMRK
Name des UnternehmensMerck & Co Inc
IPO-datumFeb 06, 2077
CEODavis (Robert M)
Anzahl der mitarbeiter75000
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 06
Addresse126 East Lincoln Avenue
StadtRAHWAY
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07065
Telefon19087404000
Websitehttps://www.merck.com/
BörsenkürzelMRK
IPO-datumFeb 06, 2077
CEODavis (Robert M)

Führungskräfte von Merck & Co Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
70.41K
+2.13%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
56.20K
+1.78%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Mr. Inge G. Thulin
Mr. Inge G. Thulin
Independent Director
Independent Director
2.93K
--
Ms. Pamela J. Craig
Ms. Pamela J. Craig
Independent Director
Independent Director
1.72K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
70.41K
+2.13%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
56.20K
+1.78%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Merck & Co Inc?

Die fünf größten Anteilseigner von Merck & Co Inc sind: Mr. Robert M. (Rob) Davis

Wie viele Institutionen halten Anteile an Merck & Co Inc (MRK)?

Mit Stand vom 2026Q1 halten 5687 Institutionen Anteile an Merck & Co Inc, mit einem Gesamtmarktwert von etwa 2.01B, was 81.41% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -10595247.00 gestiegen.

Was ist die größte Einnahmequelle von Merck & Co Inc?

Am 2026Q1 erzielte das Geschäft mit Oncology-Keytruda für Merck & Co Inc den höchsten Umsatz in Höhe von 31.64B, was 48.67% des Gesamtumsatzes entspricht.